DANVERS, Mass., Jan 27, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD) ("Abiomed"), a leading provider of breakthrough
heart support technologies designed for heart recovery, today announced
a strategic partnership with Opsens (TSX VENTURE EXCHANGE: OPS)
("Opsens"), a leading developer of fiber optic sensors. Through this
partnership, Opsens' breakthrough sensor technology will be integrated
into the Impella(R) catheter to provide robust blood pressure
measurements that can be used to enhance Impella's performance and
ease-of-use.
Impella, the World's Smallest Heart Pump, has supported more than 1,600
patients in the U.S. and more than 3,000 patients worldwide. Over the
past fiscal year 2010, product enhancements to the Impella have included
a new introducer sheath and a quick set-up software and kit, which have
allowed customers to reduce the Impella set-up time from 11 minutes to 2
minutes.
Through this latest enhancement, Opsens' fiber optic sensors will be
integrated into the Impella catheter and will allow for further
improvements in set-up time, as well as provide a high-quality pressure
monitoring capability that can eventually be used to help automate the
control and operation of the Impella pump. Unlike current fiber optic
sensors used on other cardiac assist devices today such as certain
Intra-Aortic Balloons (IABs), Opsens' fiber optic sensor is designed to
provide longer-term accuracy and reliability.
"This partnership with Opsens further demonstrates Abiomed's commitment
to continue enhancing and updating Impella technology and providing
better results for customers," said David M. Weber, Chief Operating
Officer of Abiomed. "By integrating Opsens' technology into our Impella
platform, we can provide our customers with even more calculated control
and insight during their high-risk and emergent procedures."
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of
medical devices that provide circulatory support to acute heart failure
patients across the continuum of care in heart recovery. Our products
are designed to enable the heart to rest, heal and recover by improving
blood flow and/or performing the pumping of the heart. For additional
information please visit: www.abiomed.com.
About Opsens (www.opsens.com)
Opsens is a leading developer, manufacturer and supplier of a wide range
of fiber optic sensors and associated signal conditioners based on
proprietary patented and patent pending technologies. Opsens' sensors
provide long-term accuracy and reliability in the harshest environments.
Opsens provides sensors to measure pressure, temperature, strain and
displacement to original equipment manufacturers (OEM) and end-users in
the oil and gas, medical, high-power transformers, and laboratory
fields. Opsens provides complete technical support, including
installation, training, after-sales service, for its fiber optics
systems that are regulated by the ISO 9001-2008 norm.
FORWARD-LOOKING STATEMENTS
This Release contains forward-looking statements, including statements
regarding development of Abiomed's existing and new products, the
Company's progress toward commercial growth, and future opportunities
and expected regulatory approvals. The Company's actual results may
differ materially from those anticipated in these forward-looking
statements based upon a number of factors, including uncertainties
associated with development, testing, regulatory approvals, anticipated
future losses, complex manufacturing, high quality requirements,
dependence on limited sources of supply, competition, technological
change, government regulation, future capital needs and uncertainty of
additional financing, and other risks and challenges detailed in the
Company's filings with the Securities and Exchange Commission, including
the Annual Report filed on Form 10-K and the most recently filed
Quarterly Report on Form 10-Q. Readers are cautioned not to place undue
reliance on any forward-looking statements, which speak only as of the
date of this Release. The Company undertakes no obligation to publicly
release the results of any revisions to these forward-looking statements
that may be made to reflect events or circumstances that occur after the
date of this Release or to reflect the occurrence of unanticipated
events.
Abiomed, Impella, iPulse, BVS5000, AB5000, AbioCor and the Abiomed
logo are all trademarks of Abiomed. Other company and product names may
be trademarks of their respective owners.

SOURCE: Abiomed, Inc.
Abiomed
Paula Carpinella, 978-646-1816
ir@abiomed.com